The Joint Corp.
NASDAQ:JYNTMedical - Care Facilities
+$0.17 today
- Market cap
- $91.03M
- Beta
- 1.10
- P/E (TTM)
- 40.7
- EPS (TTM)
- $0.23
Volume 0.05M
Average 0.07M
JYNT EBITDA
Earnings before interest, taxes, depreciation, and amortization; a proxy for operating profit before non-cash and financing charges.
The Joint Corp.NASDAQ: JYNT
EBITDA · Q1 FY2026 · quarter ended Mar 2026
EBITDA turns positive
Q1 FY2026 EBITDA was $1.51M, compared with -$288.25K a year earlier. Trailing-twelve-month EBITDA was $2.94M. Over 3 fiscal years it compounded at -42.7% a year.
Context
- EBITDA amounted to 2.7% of revenue in FY2025, down 2.9 pp from a year earlier.
- EBITDA increased in 1 of the last 3 fiscal years.
- FY2025 was the lowest annual figure in the 4 fiscal years shown.
What to watch
Whether EBITDA reaches the consensus estimate from 3 analysts of $6.73M (+353.5%) for the fiscal year ending Dec 2026, a step up from the -48.8% reported in FY2025.
Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterMar 2026
- $1.51M+9.2% QoQ
- Last fiscal yearDec 2025
- $1.48M-48.8% YoY
- LTMMar 2026
- $2.94M+2328.8% YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | +624.1% | +276.6% | -347.5 pp |
| 1 year | -48.8% | +353.5% | +402.3 pp |
| 3-year CAGR | -42.7% | +18.0% | +60.7 pp |
| 5-year CAGR | — | — | |
| 10-year CAGR | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
EBITDA history
USD · from the income statement
- Latest · FY2025
- 1.48M USD
- Year-over-year change
- -48.8%
- 4-year CAGR
- -38.0%
| Period | Period end | EBITDA | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 1.48M | -48.8% |
| FY2024 | 2024-12-31 | 2.9M | -67.4% |
| FY2023 | 2023-12-31 | 8.88M | +12.6% |
| FY2022 | 2022-12-31 | 7.89M | -21.7% |
| FY2021 | 2021-12-31 | 10.07M | — |
EBITDA vs competitors
How JYNT compares with its peers on the latest reported figures
- JYNT's LTM Mar 2026 EBITDA of $2.94M is the 3rd highest of the 11 companies compared; the peer median is -$37.67M.
- Its year-over-year change of +2328.8% is the highest of 11, against a peer median of -2.9%.
- EBITDA amounts to 5.2% of revenue for JYNT, versus a peer median of 91.5%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $37.29M | -29.9% | +88.3% | 19.8% | |
| LTM Mar 2026 | $28.3M | +17.2% | +10.4% | 22.8% | |
| LTM Mar 2026 | $2.94M | +2328.8% | -42.7% | 5.2% | |
| LTM Mar 2026 | -$2.44M | +81.8% | — | 4.4% | |
| LTM Mar 2026 | -$19.31M | +41.5% | — | — | |
| LTM Mar 2026 | -$31.22M | +2.8% | — | 54764.9% | |
| LTM Mar 2026 | -$44.12M | +27.6% | — | 859.3% | |
| LTM Mar 2026 | -$45.12M | -8.6% | — | 131.2% | |
| LTM Mar 2026 | -$53.92M | -39.7% | — | — | |
| LTM Mar 2026 | -$156.43M | -1199.8% | — | 51.8% | |
| LTM Mar 2026 | -$341.95M | -5893.3% | — | 86155.0% | |
| Peer median (excluding JYNT) | -$37.67M | -2.9% | +49.3% | 91.5% | |
Competitors are the stored peer set for JYNT. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 80.01M | 101.25M | 46.98M | 52.16M | 54.9M |
| Cost of Revenue | 7.67M | 9.17M | 10.48M | 11.52M | 11.23M |
| Gross Profit | 72.35M | 92.08M | 36.5M | 40.65M | 43.67M |
| Gross Margin | 90.4% | 90.9% | 77.7% | 77.9% | 79.6% |
| Research & Development | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | 62.27M | 81.95M | 34.92M | 41.1M | 42.93M |
| Operating Expenses | 66.22M | 91.25M | 36.18M | 42.54M | 44.58M |
| Depreciation & Amortization | 3.92M | 6.65M | 8.58M | 4.72M | 1.71M |
| EBITDA | 10.07M | 7.89M | 8.88M | 2.9M | 1.48M |
| EBITDA Margin | 12.6% | 7.8% | 18.9% | 5.6% | 2.7% |
| Operating Income | 6.13M | 828.25K | 318.3K | (1.89M) | (905.48K) |
| Operating Margin | 7.7% | 0.8% | 0.7% | -3.6% | -1.6% |
| Interest Income | 0 | 133.1K | 0 | 280.29K | 0 |
| Interest Expense | 0 | 953.53K | 64.29K | 0 | 0 |
| Other Income / Expenses | (69.88K) | (133.1K) | (64.29K) | 280.29K | 675.97K |
| Income Before Tax | 6.06M | 695.15K | 254.01K | (1.61M) | (229.5K) |
| Pre-Tax Margin | 7.6% | 0.7% | 0.5% | -3.1% | -0.4% |
| Income Tax Expense | (1.51M) | 68.45K | 11.02M | 5.61K | 38.65K |
| Net Income | 7.57M | 626.71K | (9.75M) | (5.8M) | 2.91M |
| Net Margin | 9.5% | 0.6% | -20.8% | -11.1% | 5.3% |
| EPS (Basic) | 0.46 | 0.04 | (0.66) | (0.39) | 0.19 |
| EPS (Diluted) | 0.44 | 0.04 | (0.66) | (0.39) | 0.19 |
| Weighted Avg Shares | 14.32M | 14.49M | 14.69M | 14.92M | 15.13M |
| Weighted Avg Shares (Diluted) | 14.94M | 14.87M | 14.69M | 15.15M | 15.13M |
The Joint Corp.
NASDAQ:JYNT
Intrinsic Alpha fair value
Locked
Current Price
$6.65
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.